Work

Phase 1/2 trial of Pb-212-VMT-alpha-NET in GI neuroendocrine tumors and pheochromocytoma/paraganglioma previously treated with radioligand therapy

Year: 2023

Type: conference-abstract

Source: Endocrine Abstracts

DOI: 10.1530/endoabs.98.t3

Authors: Frank I. Lin, Rivero Jaydira Del, Jorge Carrasquillo, Inna Shamis, Joy Zou, Baris Turkbey, Joanna Klubo, Esther Mena, Liza Lindenberg, Clara Chen, Peter Herscovitch, Corina Millo, Karel Pacak

Language: English

Topic: Neuroendocrine Tumor Research Advances

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4389893885

Cites:

Cited by:

Related to: 10